Long-Term Study of Middle-Aged Mice Shows Resveratrol Improves Health and Mimics Some Benefits of Dietary Restriction

July 03, 2008

Cubist to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V.

July 02, 2008

Cubist to Announce 2Q08 Financial Results on July 17, 2008

July 01, 2008

Cubist Testifies on Need to Encourage Antibiotic Research and Development

June 24, 2008

Cubist Appoints Mark H.N. Corrigan, M.D., to its Board of Directors

June 24, 2008

Alnylam and Kyowa Hakko Form Alliance for the Development and Commercialization of ALN-RSV01 in Asia

June 19, 2008

athenahealth Appoints New General Counsel

June 19, 2008

Cubist Appoints Nancy J. Hutson, Ph.D., to its Board of Directors

June 16, 2008

Wayne State University Physician Group Selects athenahealth's Centrally-Hosted Practice Management Services

June 05, 2008

GLAXOSMITHKLINE SUCCESSFULLY COMPLETES TENDER OFFER FOR SHARES OF SIRTRIS PHARMACEUTICALS

June 02, 2008

Aetna Ranks First in 2008 PayerView(SM) Ranking; Pays Medical Providers the Fastest Among National Commercial Insurers

May 29, 2008

athenahealth to Release 2008 PayerView(SM) Rankings

May 28, 2008

Alnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi Therapeutics

May 27, 2008

Alnylam and Collaborators Publish In Vivo Research on Validation of a Mammalian Host Gene Involved in Malaria Infection and on the Anti-Parasitic Efficacy of RNAi Therapeutics

May 13, 2008

Alnylam Pharmaceuticals Reports First Quarter 2008 Financial Results

May 08, 2008

Momenta Pharmaceuticals Reports Financial Results for the First Quarter of 2008

May 07, 2008

Rib-X Pharmaceuticals, Inc. Appoints Nancy Motola as Senior Vice President of Regulatory Affairs

May 06, 2008

athenahealth, Inc. Reports First-Quarter 2008 Results

May 06, 2008

Regulus Therapeutics Exclusively Licenses Intellectual Property from Stanford University Relating to microRNA Antagonists to Treat Inflammatory Diseases

May 06, 2008

Thomson Reuters and Lance Armstrong Foundation Provide Online Cancer Information

May 06, 2008

GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals

May 02, 2008

Connecticut State Medical Society Joins with athenahealth to Offer On-Demand Practice Management Services to Physicians Statewide

May 02, 2008

Sirtris Pharmaceuticals Reports First Quarter 2008 Financial Results

May 01, 2008

Momenta Pharmaceuticals Receives Regulatory Guidance On M-Enoxaparin ANDA

April 29, 2008

GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in 'Sirtuin' Research and Development

April 22, 2008

Alnylam Initiates Phase II Trial to Evaluate Safety and Tolerability of ALN-RSV01 in Adult Lung Transplant Patients Naturally Infected with Respiratory Syncytial Virus (RSV) Infection

April 09, 2008

athenahealth, Inc. Reports Fourth-Quarter and Full-Year 2007 Results

March 05, 2008

Sirtris Pharmaceuticals' SRT501 Slows Retinal Ganglion Cell Loss During Optic Neuritis in a Preclinical Model of Multiple Sclerosis

March 04, 2008

Thomson Healthcare Cancer Profiler used in study

March 03, 2008

athenahealth Awarded Community Health Systems Contract

February 27, 2008

Sirtris Pharmaceuticals Reports Fourth Quarter and 2007 Financial Results; Significant Progress Achieved

February 25, 2008

Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year End 2007

February 14, 2008

Leonard P. Guarente, a Founder of the Sirtuin Field, Signs Exclusive Consulting Agreement with Sirtris Pharmaceuticals

February 05, 2008

Thomson Healthcare online treatment tools mark milestone

February 02, 2008

athenahealth's National Physician Network Live With New Centers for Medicare and Medicaid Services Pay-For-Performance Measures

January 29, 2008

Alnylam Announces Grant of New Patent Covering RNAi Therapeutics in the United Kingdom

January 28, 2008

AccentCare Newport Beach Ranked Among the Top 25 Percent of Home Health Providers in the Country for 2007

January 23, 2008

Cubist Pharmaceuticals Reports GAAP Diluted Net Income of $0.16 Per Share in Fourth Quarter 2007 and GAAP Diluted Net Income of $0.85 Per Share for Full Year 2007

January 23, 2008

Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741

January 04, 2008

Cubist Pharmaceuticals Acquires Illumigen Biosciences

December 26, 2007

athenahealth Announces Senior Management Addition and Changes

December 14, 2007

Sirtris Pharmaceuticals' SIRT1 Activator Controls Glucose as well as a DPP-4 inhibitor in a Pre-Clinical Model of Type 2 Diabetes

December 13, 2007

Sirtris and Harvard Unveil Promising, Novel SIRT1 Activators for Treating Diseases of Aging; Therapeutic Type 2 Diabetes Data Published in the Journal Nature

November 28, 2007

Alnylam Announces Grant of Broad Patent Covering RNAi Therapeutics in Germany

November 26, 2007